Publicacions en col·laboració amb investigadors/es de Hospital General de Ciudad Real (17)

2024

  1. Sodium-glucose cotransporter 2 inhibition in primary and secondary glomerulonephritis

    Nephrology Dialysis Transplantation, Vol. 39, Núm. 2, pp. 328-340

2023

  1. Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy

    Kidney360, Vol. 4, Núm. 5, pp. 659-672

  2. Effect of Immunosuppressive Treatments on Kidney Outcomes After Gross Hematuria-Related Acute Kidney Injury in Older Patients With IgA Nephropathy

    Kidney International Reports, Vol. 8, Núm. 8, pp. 1596-1604

2022

  1. Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathy

    Clinical Kidney Journal, Vol. 15, Núm. 9, pp. 1737-1746

  2. Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 7, pp. 1270-1280

2021

  1. The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy

    Kidney International, Vol. 99, Núm. 4, pp. 986-998

  2. Validation of a Histologic Scoring Index for C3 Glomerulopathy

    American Journal of Kidney Diseases, Vol. 77, Núm. 5, pp. 684-695.e1

2020

  1. Mycophenolate mofetil in c3 glomerulopathy and pathogenic drivers of the disease

    Clinical Journal of the American Society of Nephrology, Vol. 15, Núm. 9, pp. 1287-1298

2019

  1. Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome

    Kidney International, Vol. 96, Núm. 4, pp. 995-1004

2018

  1. Changes in the clinical presentation of immunoglobulin A nephropathy: Data from the Spanish Registry of Glomerulonephritis

    Nephrology Dialysis Transplantation, Vol. 33, Núm. 3, pp. 472-477

2017

  1. Eculizumab in secondary atypical haemolytic uraemic syndrome

    Nephrology Dialysis Transplantation, Vol. 32, Núm. 3, pp. 466-474

2015

  1. Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus

    Nephrology Dialysis Transplantation, Vol. 30, Núm. 3, pp. 467-474

2013

  1. Mycophenolate as maintenance therapy for lupus nephritis with impaired renal function

    American Journal of Nephrology, Vol. 37, Núm. 6, pp. 509-517

2012

  1. Mycophenolate as induction therapy in lupus nephritis with renal function impairment

    American Journal of Nephrology, Vol. 35, Núm. 5, pp. 424-433

  2. Spontaneous remission of nephrotic syndrome in membranous nephropathy with chronic renal impairment

    Nephrology Dialysis Transplantation, Vol. 27, Núm. 1, pp. 231-234

2010

  1. Atheroembolic renal disease: Analysis of clinical and therapeutic factors that influence its progression

    Nefrologia, Vol. 30, Núm. 3, pp. 317-323

  2. Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy

    Journal of the American Society of Nephrology, Vol. 21, Núm. 4, pp. 697-704